EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PRMT5 regulates alternative splicing of TCF3 under hypoxia to promote EMT and invasion in breast cancer

Srinivas Abhishek Mutnuru, Pooja Yadav, Parik Kakani, Shruti Ganesh Dhamdhere, Poorva Kumari, Shruti Agrawal, Atul Samaiya, Sanjeev Shukla iD

PLOS Biology · 2025

DOI: 10.1371/journal.pbio.3003444 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Biology, 2025. Verfasst von Srinivas Abhishek Mutnuru und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Indian Institute of Science Education and Research Bhopal, Bhopal, Madhya Pradesh, India. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, Alternative Splicing, Breast Neoplasms, Epithelial-Mesenchymal Transition. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Institute of Science Education and Research-Bhopal, India, Council of Scientific and Industrial Research fellowship, India, Department of Biotechnology (DBT, India).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor hypoxia induced alterations in the epigenetic landscape and alternative splicing influence cellular adaptations. PRMT5 is a type II protein arginine methyltransferase that regulates several tumorigenic events in many cancer types. However, the regulation of PRMT5 and its direct implication on aberrant alternative splicing under hypoxia remains unexplored. In this study, we observed hypoxia-induced upregulation of PRMT5 via the CTCF in human breast cancer cells. Further, PRMT5-mediated symmetric arginine dimethylation H4R3me2s and H3R8me2s directly regulated the alternative splicing of TCF3 . Under hypoxia, PRMT5-mediated histone dimethylation at the intronic conserved region (ICR) present between TCF3 exon 18a and exon 18b recruits DNMT3A, resulting in DNA methylation. DNA methylation at the TCF3 -ICR is recognized and bound by MeCP2 resulting in RNA-Pol II pausing, promoting the recruitment of the negative splicing factor PTBP1 to the splicing locus of TCF3 pre-mRNA. PTBP1 promotes the exclusion of exon 18a which results in the production of the pro-invasive TCF3-18B (E47) isoform which promotes EMT and invasion of breast cancer cells under hypoxia. Collectively, our results indicate PRMT5-mediated symmetric arginine dimethylation of histones regulates alternative splicing of TCF3 gene thereby enhancing EMT and invasion in breast cancer hypoxia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein-Arginine N-MethyltransferasesAlternative SplicingBreast NeoplasmsEpithelial-Mesenchymal TransitionBasic Helix-Loop-Helix ProteinsHumansFemaleDNA MethylationCell Line, TumorGene Expression Regulation, NeoplasticNeoplasm InvasivenessRepressor ProteinsCCCTC-Binding FactorHistonesDNA Methyltransferase 3ACell HypoxiaExonsMCF-7 Cells

Substanzen

Protein-Arginine N-MethyltransferasesBasic Helix-Loop-Helix ProteinsRepressor ProteinsCCCTC-Binding FactorHistonesDNA Methyltransferase 3APRMT5 protein, humanTCF3 protein, humanCTCF protein, humanDNMT3A protein, human

Autor:innen und Institutionen

  • Department of Biological Sciences, Indian Institute of Science Education and Research Bhopal, Bhopal, Madhya Pradesh, India.
  • Department of Pathology, Bansal Hospital, Bhopal, Madhya Pradesh, India.
  • Department of Surgical Oncology, Bansal Hospital, Bhopal, Madhya Pradesh, India.

ORCID-Profile: Sanjeev Shukla

Förderung

  • Indian Institute of Science Education and Research-Bhopal, India
  • Council of Scientific and Industrial Research fellowship, India
  • Department of Biotechnology (DBT, India)
  • Indian Institute of Science Education and Research
  • Council of Scientific and Industrial Research
  • Beth Israel Deaconess Medical Center
  • Department of Biotechnology India
  • Science and Engineering Research Board

Zitieren

APA

Mutnuru, S. A., Yadav, P., Kakani, P., Dhamdhere, S. G., Kumari, P., Agrawal, S., Samaiya, A., & Shukla, S. (2025). PRMT5 regulates alternative splicing of TCF3 under hypoxia to promote EMT and invasion in breast cancer. PLOS Biology. https://doi.org/10.1371/journal.pbio.3003444

Vancouver

Mutnuru SA, Yadav P, Kakani P, Dhamdhere SG, Kumari P, Agrawal S, et al. PRMT5 regulates alternative splicing of TCF3 under hypoxia to promote EMT and invasion in breast cancer. PLOS Biology. 2025. doi:10.1371/journal.pbio.3003444

BibTeX
@article{Mutnuru2025,
  author = {Mutnuru, Srinivas Abhishek and Yadav, Pooja and Kakani, Parik and Dhamdhere, Shruti Ganesh and Kumari, Poorva and Agrawal, Shruti and Samaiya, Atul and Shukla, Sanjeev},
  title = {PRMT5 regulates alternative splicing of TCF3 under hypoxia to promote EMT and invasion in breast cancer},
  journal = {PLOS Biology},
  year = {2025},
  doi = {10.1371/journal.pbio.3003444}
}
Kostenlos starten →